Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Charlotte Retzler has worked on the following 6 EPO patent applications which have been published in the last five years:

EP14180875

Pharmaceutical composition containing botulinum neurotoxin A2

IPC classification:
A61K 8/99, A61K 9/00, A61K 38/48, A61K 47/26, A61P 1/00, A61P 5/00, A61P 11/00, A61P 13/00, A61P 17/00, A61P 21/00, A61P 25/14, A61P 27/00, A61P 29/00, A61P 37/00, A61Q 7/00, A61Q 19/08
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
PATENT GRANTED
EP13290175

Aqueous sustained release compositions of LHRH analogs

IPC classification:
A61K 9/00, A61K 38/09, A61K 47/02
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
APPLICATION REFUSED
EP15000178

Pharmaceutical compositions comprising botulinum neurotoxin

IPC classification:
A61K 9/00, A61K 9/19, A61K 38/48, A61K 47/26, A61K 47/30
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
GRANT OF PATENT INTENDED
EP13900760

NOVEL IMIDAZOLIDINE-2, 4-DIONE DERIVATIVES

IPC classification:
A61K 31/4166, A61P 35/00, C07D 403/06
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
EXAMINATION REQUESTED
EP13900705

NOVEL IMIDAZOLIDINE-2,4-DIONE DERIVATIVES

IPC classification:
A61K 31/4166, A61P 35/00, C07D 403/06, C07D 403/14, C07D 417/06, C07D 417/14
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
EXAMINATION REQUESTED
EP16181468

THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY

IPC classification:
A61K 35/74, A61K 38/16, A61P 25/02, A61P 25/04, A61P 29/00
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature